About N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide
N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide (PubChem CID 154736341) has the molecular formula C17H20N4O3
and a molecular weight of 328.37 g/mol. Its IUPAC name is N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide.
Analyze N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide?
The IUPAC name of N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide (CID 154736341) is N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide.
What is the SMILES notation for N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide?
The canonical SMILES for N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide is O=C(NC1CCN(C2CCOCC2)C1=O)c1cnn2ccccc12.
What is the InChIKey of N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide?
The InChIKey is HCGLGHVVVWWNIZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H20N4O3/c22-16(13-11-18-21-7-2-1-3-15(13)21)19-14-4-8-20(17(14)23)12-5-9-24-10-6-12/h1-3,7,11-12,14H,4-6,8-10H2,(H,19,22).
What are the key properties of N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide?
N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide has a molecular weight of 328.37 g/mol, XLogP of 0.84, 3 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-(oxan-4-yl)-2-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyridine-3-carboxamide is sourced from PubChem (CID 154736341), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).